Mary S. Rosendahl
Loxo Oncology at Lilly (United States)(US)
Publications by Year
Research Areas
Bacterial Genetics and Biotechnology, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis, HIV/AIDS Research and Interventions
Most-Cited Works
- → Inhibition of Human Immunodeficiency Virus Type 1 Infectivity by Secretory Leukocyte Protease Inhibitor Occurs Prior to Viral Reverse Transcription(1997)245 cited
- → Identification and Characterization of a Pro-tumor Necrosis Factor-α-processing Enzyme from the ADAM Family of Zinc Metalloproteases(1997)199 cited
- → A Long-Acting, Highly Potent Interferon α-2 Conjugate Created Using Site-Specific PEGylation(2005)106 cited
- → Potent inhibitory effects of glial derived neurotrophic factor against kainic acid mediated seizures in the rat(1995)105 cited
- → Chemical Synthesis and Biological Studies on Mutated Gene-control Regions(1983)88 cited
- → Pirtobrutinib preclinical characterization: a highly selective, non-covalent (reversible) BTK inhibitor(2023)86 cited
- → Site-Specific PEGylation of Engineered Cysteine Analogues of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor(2005)77 cited
- → Adenosine cyclic 3',5'-monophosphate dependent protein kinase: a new fluorescence displacement titration technique for characterizing the nucleotide binding site on the catalytic subunit(1983)76 cited
- → Enhanced Circulating Half-Life and Antitumor Activity of a Site-Specific Pegylated Interferon-α Protein Therapeutic(2007)62 cited
- → A Long-Acting, Mono-PEGylated Human Growth Hormone Analog Is a Potent Stimulator of Weight Gain and Bone Growth in Hypophysectomized Rats(2007)53 cited